Does Rallies show 13F holders for AXGN?

Yes. Rallies tracks hedge fund and 13F ownership data for AXGN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is AXGN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AXGN. It does not provide personalized investment advice.

AXGN (Axogen, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Axogen, Inc. Common Stock (AXGN) is a publicly traded Healthcare sector company. As of May 21, 2026, AXGN trades at $42.94 with a market cap of $2.23B and a P/E ratio of -67.85. AXGN moved -0.07% today. Year to date, AXGN is +34.41%; over the trailing twelve months it is +268.97%. Its 52-week range spans $9.22 to $45.83. Analyst consensus is strong buy with an average price target of $50.14. Rallies surfaces AXGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns AXGN stock?

Hedge funds tracked by Rallies that own AXGN include Panagora Asset, Centerbook Partners, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Axogen, Inc. Common Stock.

AXGN Key Metrics

Key financial metrics for AXGN
Metric	Value
Price	$42.94
Market Cap	$2.23B
P/E Ratio	-67.85
EPS	$-0.63
Dividend Yield	1.00%
52-Week High	$45.83
52-Week Low	$9.22
Volume	32
Avg Volume	0
Revenue (TTM)	$238.10M
Net Income	$-31.45M
Gross Margin	75.01%

Top Hedge Funds Holding AXGN

Panagora Asset holds 73.98K shares of AXGN, changed -43.31% as of Mar 31, 2026.
Centerbook Partners holds 37.28K shares of AXGN, changed +0.00% as of Jun 30, 2025.
Pinebridge Investments holds 2.15K shares of AXGN, changed +0.00% as of Jun 30, 2023.

Latest AXGN News

Axogen Reports 26.6% Q1 Revenue Growth to $61.5M, Guides $270M in 2026 — Apr 29, 2026
Axogen Secures FDA Approval with 12-Year Exclusivity, Posts 20% Q4 Revenue Growth — Feb 19, 2026
Axogen CEO Sells $750K Shares, Cuts Direct Holdings by 28% — Jan 15, 2026

Recent AXGN Insider Trades

JOHNSON JOHN sold 11.05K (~$477.97K) on May 7, 2026.
Weiler Kathy Johnson sold 16.34K (~$720.62K) on May 7, 2026.
Kemp Jens sold 4.00K (~$173.76K) on May 7, 2026.

AXGN Analyst Consensus

7 analysts cover AXGN: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.14.

Common questions about AXGN

Who owns AXGN stock?: Hedge funds tracked by Rallies that own AXGN include Panagora Asset, Centerbook Partners, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Axogen, Inc. Common Stock.
Does Rallies show 13F holders for AXGN?: Yes. Rallies tracks hedge fund and 13F ownership data for AXGN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is AXGN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AXGN. It does not provide personalized investment advice.